What does DR. K. GLADYS DERMATOLOGIE do?

DR. K. GLADYS DERMATOLOGIE is a specialist medical practice in Genk. Private Limited, started on 24 May 2002, 1 establishment.

What is the address of DR. K. GLADYS DERMATOLOGIE?

The registered office of DR. K. GLADYS DERMATOLOGIE is located at Onderwijslaan 81, 3600 Genk.

Is DR. K. GLADYS DERMATOLOGIE still active?

Yes. According to the CBE (29 September 2026) DR. K. GLADYS DERMATOLOGIE is active, legal situation “Normale toestand”, started on 24 May 2002.

Is DR. K. GLADYS DERMATOLOGIE registered on Peppol?

Yes, DR. K. GLADYS DERMATOLOGIE is registered on the Peppol network with ID 0208:0477611667.

What is the enterprise number of DR. K. GLADYS DERMATOLOGIE?

The enterprise number of DR. K. GLADYS DERMATOLOGIE is BE0477611667.

When was DR. K. GLADYS DERMATOLOGIE founded?

DR. K. GLADYS DERMATOLOGIE was founded on 24 May 2002.

Who are the directors of DR. K. GLADYS DERMATOLOGIE?

According to the 2025 annual accounts, the directors of DR. K. GLADYS DERMATOLOGIE are: KRZYSZTOFA GLADYS.

Is DR. K. GLADYS DERMATOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 May 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. K. GLADYS DERMATOLOGIE make in 2025?

DR. K. GLADYS DERMATOLOGIE posted a profit after taxes of € 174,259 in financial year 2025.

What is the revenue of DR. K. GLADYS DERMATOLOGIE?

As a small company, DR. K. GLADYS DERMATOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 321,292.

DR. K. GLADYS DERMATOLOGIE (Private Limited) - Genk

Dossier DR. K. GLADYS DERMATOLOGIE, printed on 29 September 2026 from databakkes.be/en/0477611667/dr-k-gladys-dermatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. K. GLADYS DERMATOLOGIE from Genk, company number BE0477611667, closed financial year 2025 with a result of € 174,259 after tax. For that financial year DR. K. GLADYS DERMATOLOGIE recorded a gross margin of € 321,292 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 146,296 to € 174,259. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Growing

€ 1.7 million

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 174,259

▲ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 564,986

▲ 57% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.7 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 856

▲ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 61,982

▲ 39% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 244,180 Gross margin 2022: € 244,180 First fiscal year in the series	€ 271,250 Gross margin 2023: € 271,250 ▲ 11% vs 2022 (€ 244,180) Favourable step	€ 285,220 Gross margin 2024: € 285,220 ▲ 5% vs 2023 (€ 271,250) Favourable step	€ 321,292 Gross margin 2025: € 321,292 ▲ 13% vs 2024 (€ 285,220) Favourable step	▲ 13%
Profit after taxes	€ 148,183 Profit after taxes 2022: € 148,183 First fiscal year in the series	€ 164,198 Profit after taxes 2023: € 164,198 ▲ 11% vs 2022 (€ 148,183) Favourable step	€ 146,296 Profit after taxes 2024: € 146,296 ▼ 11% vs 2023 (€ 164,198) Unfavourable step	€ 174,259 Profit after taxes 2025: € 174,259 ▲ 19% vs 2024 (€ 146,296) Favourable step	▲ 19%
Equity	€ 1,561,979 Equity 2022: € 1,561,979 First fiscal year in the series	€ 1,356,277 Equity 2023: € 1,356,277 ▼ 13% vs 2022 (€ 1,561,979) Unfavourable step	€ 1,502,573 Equity 2024: € 1,502,573 ▲ 11% vs 2023 (€ 1,356,277) Favourable step	€ 1,676,832 Equity 2025: € 1,676,832 ▲ 12% vs 2024 (€ 1,502,573) Favourable step	▲ 12%
Total debts	€ 274,228 Total debts 2022: € 274,228 First fiscal year in the series	€ 667,546 Total debts 2023: € 667,546 ▲ 143% vs 2022 (€ 274,228) Unfavourable step	€ 676,597 Total debts 2024: € 676,597 ▲ 1% vs 2023 (€ 667,546) Unfavourable step	€ 692,401 Total debts 2025: € 692,401 ▲ 2% vs 2024 (€ 676,597) Unfavourable step	▲ 2%
Cash	€ 583,295 Cash 2022: € 583,295 First fiscal year in the series	€ 782,799 Cash 2023: € 782,799 ▲ 34% vs 2022 (€ 583,295) Favourable step	€ 359,427 Cash 2024: € 359,427 ▼ 54% vs 2023 (€ 782,799) Unfavourable step	€ 564,986 Cash 2025: € 564,986 ▲ 57% vs 2024 (€ 359,427) Favourable step	▲ 57%
Land & buildings	€ 487,816 Land & buildings 2022: € 487,816 First fiscal year in the series	€ 471,729 Land & buildings 2023: € 471,729 ▼ 3% vs 2022 (€ 487,816) Unchanged	€ 455,643 Land & buildings 2024: € 455,643 ▼ 3% vs 2023 (€ 471,729) Unchanged	€ 439,556 Land & buildings 2025: € 439,556 ▼ 4% vs 2024 (€ 455,643) Unchanged	▼ 4%
Retained profit	€ 1,173,479 Retained profit 2022: € 1,173,479 First fiscal year in the series	€ 1,337,677 Retained profit 2023: € 1,337,677 ▲ 14% vs 2022 (€ 1,173,479) Favourable step	€ 1,483,973 Retained profit 2024: € 1,483,973 ▲ 11% vs 2023 (€ 1,337,677) Favourable step	€ 1,658,232 Retained profit 2025: € 1,658,232 ▲ 12% vs 2024 (€ 1,483,973) Favourable step	▲ 12%
Balance sheet total	€ 1,836,207 Balance sheet total 2022: € 1,836,207 First fiscal year in the series	€ 2,023,823 Balance sheet total 2023: € 2,023,823 ▲ 10% vs 2022 (€ 1,836,207) Unchanged	€ 2,179,170 Balance sheet total 2024: € 2,179,170 ▲ 8% vs 2023 (€ 2,023,823) Unchanged	€ 2,369,233 Balance sheet total 2025: € 2,369,233 ▲ 9% vs 2024 (€ 2,179,170) Unchanged	▲ 9%

Key figures of DR. K. GLADYS DERMATOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. K. GLADYS DERMATOLOGIE?

What happened at DR. K. GLADYS DERMATOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 174,259 (▲ 19% vs 2024). filed late Source: NBB ↗
Jun 5, 2002 New establishment in Genk. KBO
May 24, 2002 Start of the company according to the CBE. KBO
2002 KRZYSZTOFA GLADYS became a director. NBB

In short

From € 148,183 profit in 2022 to € 174,259 profit in 2025.

Paid € 285,322 in corporate taxes since 2022.

Best year ever: 2025, with € 174,259 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DR. K. GLADYS DERMATOLOGIE? We notify you, reason included.

Follow DR. K. GLADYS DERMATOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

KRZYSZTOFA GLADYS

DR. K. GLADYS DERMATOLOGIE

Behind DR. K. GLADYS DERMATOLOGIE is KRZYSZTOFA GLADYS.

See the full network in the app

Directors

According to the 2025 annual accounts

KRZYSZTOFA GLADYS

Director

since 2002

Establishments

Establishment units

Physical locations of this company

Registered office

Onderwijslaan 81

3600 Genk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

DOKTERSPRAKTIJK HERWIG VAN AERDE

€ 355,303 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0477.611.667
VAT number: BE 0477.611.667
Registered office: Onderwijslaan 81, 3600 Genk
Names & denominations: DR. K. GLADYS DERMATOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 May 2002
Peppol: Active · Active since 30 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗